Legislative/Judicial/Regulatory Updates
The Centers for Medicare & Medicaid Services (CMS) issued a bulletin on Sept. 30, Opportunity for States to Participate in a Wellness Program Demonstration Project to Implement Health-Contingent Wellness Programs in the Individual Market, which would allow up to 10 states to be approved to implement nondiscriminatory health-contingent wellness programs in the individual market.
On Oct. 3, President Trump issued an executive order, Protecting and Improving Medicare for Our Nation’s Seniors, which is aimed at expanding Medicare Advantage plans, the use of telehealth, and directing agencies to expand access to Medicare medical savings accounts.
H.R. 3, The Lower Drug Costs Now Act of 2019, was introduced in the U.S. House on Sept. 19 by Rep. Frank Pallone, chairman of the Energy and Commerce Committee, which subsequently held a hearing on the bill focusing on efforts to lower prescription drug costs through direct negotiation between the secretary of Health and Human Services and pharmaceutical companies.
The Senate Finance Committee released the text of its bipartisan bill to reform drug pricing, S. 543, on Sept. 26 after previously holding a committee hearing in July. This new text focuses on inflation caps and provisions requiring transparency, such as rebate disclosures from pharmacy benefit managers.
|